CAMBRIDGE, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) platform provider, EnvoyAI™, has entered into a distribution deal with Mach7 Technologies, a leading enterprise imaging solution provider. The deal facilitates Mach7 customer access to a wide range of AI applications available via the EnvoyAI platform within the Mach7 ecosystem. EnvoyAI’s growing catalog of content includes 71 products from 30 algorithm development partners, including a large number that are already FDA cleared.
Misha Herscu, EnvoyAI’s CEO shared, “During our first deployment of the EnvoyAI platform, at Wake Radiology in Raleigh, North Carolina, we easily integrated with the Mach7 VNA. There is a natural synergy between our companies’ products as we both have a deep commitment to open interfaces and interoperability. We are extremely excited to expand our partnership by working toward harmonizing solutions for the imaging enterprise and rolling out the EnvoyAI platform and many AI solutions to current and future Mach7 customers.”Read More